The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.
CD36, a Class B Scavenger Receptor, Is Expressed on Microglia in Alzheimer's Disease Brains and Can Mediate Production of Reactive Oxygen Species in Response to β-Amyloid Fibrils
Open accessAbstract
A pathological hallmark of Alzheimer's disease is the senile plaque, composed of beta-amyloid fibrils, microglia, astrocytes, and dystrophic neurites. We reported previously that class A scavenger receptors mediate adhesion of microglia and macrophages to beta-amyloid fibrils and oxidized low-density lipoprotein (oxLDL)-coated surfaces. We also showed that CD36, a class B scavenger receptor and an oxLDL receptor, promotes H(2)O(2) secretion by macrophages adherent to oxLDL-coated surfaces. Whether CD36 is expressed on microglia, and whether it plays a role in secretion of H(2)O(2) by microglia interacting with fibrillar beta-amyloid is not known. Using fluorescence-activated cell sorting analysis and immunohistochemistry, we found that CD36 is expressed on human fetal microglia, and N9-immortalized mouse microglia. We also found that CD36 is expressed on microglia and on vascular endothelial cells in the brains of Alzheimer's disease patients. Bowes human melanoma cells, which normally do not express CD36, gained the ability to specifically bind to surfaces coated with fibrillar beta-amyloid when transfected with a cDNA encoding human CD36, suggesting that CD36 is a receptor for fibrillar beta-amyloid. Furthermore, two different monoclonal antibodies to CD36 inhibited H(2)O(2) production by N9 microglia and human macrophages adherent to fibrillar beta-amyloid by approximately 50%. Our data identify a role for CD36 in fibrillar beta-amyloid-induced H(2)O(2) production by microglia, and imply that CD36 can mediate binding to fibrillar beta-amyloid. We propose that similar to their role in the interaction of macrophages with oxLDL, class A scavenger receptors and CD36 play complimentary roles in the interactions of microglia with fibrillar beta-amyloid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, pro-oxidative events might be elicited by PCSK9 thanks to its interaction with CD36, which is expressed on microglia cells and on vascular ECs in the brain of AD patients where it promotes fibrillar Aβ-mediated H2O2 production [119].”
From The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer’s Disease: A Possible Target for the Disease Treatment (2024) · cites this paper as [119]
In the citing paper
“Microglia–Aβ interactions lead to early synapse loss39, production of neurotoxic reactive oxygen and nitrogen species (ROS and RNS), NLRP3 inflammasome activation, and production of proinflammatory cytokines and TNF27,40–42.”
From Microglia in neurodegeneration (2018) · cites this paper as [40]
In the citing paper
“SR-B2 (also called CD36) is also a microglial Aβ receptor that forms a complex with TLR-4 and TLR-6, leading to cytokine, chemokine, and ROS production, as well as microglial migration, inflammasome activation, and neurotoxicity27,40.”
From Microglia in neurodegeneration (2018) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
CD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,282
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
Suzuki, H. I., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997) · Nature · doi:10.1038/386292a0 · Cited by 1,226
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,037
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727
Self-citationβ-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703
Sedgwick, J. D., Schwender, S., Imrich, H., Dörries, R., Butcher, G. W., & ter Meulen, V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7438 · Cited by 691
Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.
Bornstein, P. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.3.503 · Cited by 666
Paresce, D. M., Ghosh, R. N., & Maxfield, F. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80187-7 · Cited by 663
Cited by
Sorted by citations
Items 101–200 of 399
Mechanism mediating oligomeric Aβ clearance by naïve primary microglia
Yang, C.-N., Shiao, Y.-J., Shie, F.-S., Guo, B.-S., Chen, P.-H., Cho, C.-Y., Chen, Y.-J., Huang, F.-L., & Tsay, H.-J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.005 · Cited by 117
Handattu, S. P., Garber, D. W., Monroe, C. E., van Groen, T., Kadish, I., Nayyar, G., Cao, D., Palgunachari, M. N., Li, L., & Anantharamaiah, G. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.007 · Cited by 125
Takeuchi, H., & Suzumura, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00189 · Cited by 127
Lee, J. K., Schuchman, E. H., Jin, H. K., & Bae, J. (2012) · Stem Cells · doi:10.1002/stem.1125 · Cited by 121
Chuang, P., Wu, M., Shoji, Y., & Tsai, S. (2009) · The Journal of Pathology · doi:10.1002/path.2588 · Cited by 117
Chuang, P., Lin, Y.-J., Wu, M., Wing, L.-Y. C., Shoji, Y., & Tsai, S. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090551 · Cited by 118
Mallick, R., Basak, S., & Duttaroy, A. K. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101116 · Cited by 126
Guedes, J. R., Lao, T., Cardoso, A. L., & El Khoury, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00549 · Cited by 115
CD36 Signals to the Actin Cytoskeleton and Regulates Microglial Migration via a p130Cas Complex
Stuart, L. M., Bell, S. A., Stewart, C. R., Silver, J. M., Richard, J., Goss, J. L., Tseng, A. A., Zhang, A., Khoury, J. B. E., & Moore, K. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702887200 · Cited by 112
Immunopathogenesis of brain abscess.
Kielian, T. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-16 · Cited by 111
Hou, L., Wang, K., Zhang, C., Sun, F., Che, Y., Zhao, X., Zhang, D., Li, H., & Wang, Q. (2018) · Redox Biology · doi:10.1016/j.redox.2017.09.017 · Cited by 104
Role of transient receptor potential ankyrin 1 channels in Alzheimer’s disease
Lee, K.-I., Lee, H., Lin, H., Tsay, H.-J., Tsai, F.-C., Shyue, S., & Lee, T. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0557-z · Cited by 113
Roberts, K., Zeineddine, R., Corcoran, L., Li, W., Campbell, I. L., & Yerbury, J. J. (2012) · Glia · doi:10.1002/glia.22444 · Cited by 107
Liang, C., Zou, T., Zhang, M., Fan, W., Zhang, T., Jiang, Y., Cai, Y., Chen, F., Chen, X., Sun, Y., et al. (2021) · Theranostics · doi:10.7150/thno.53418 · Cited by 106
Blood–brain barrier and blood–cerebrospinal fluid barrier in normal and pathological conditions
Ueno, M., Chiba, Y., Murakami, R., Matsumoto, K., Kawauchi, M., & Fujihara, R. (2016) · Brain Tumor Pathology · doi:10.1007/s10014-016-0255-7 · Cited by 106
Microglia-targeting nanotherapeutics for neurodegenerative diseases
Zhao, N., Francis, N. L., Calvelli, H. R., & Moghe, P. V. (2020) · APL Bioengineering · doi:10.1063/5.0013178 · Cited by 104
Ray, B., Chauhan, N. B., & Lahiri, D. K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07145.x · Cited by 104
Angelova, P. R., & Abramov, A. Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.103 · Cited by 98
A key role for the microglial NADPH oxidase in APP-dependent killing of neurons
Qin, B., Cartier, L., Dubois‐Dauphin, M., Li, B., Serrander, L., & Krause, K. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.036 · Cited by 99
Amyloid-β Induces Hepatic Insulin Resistance by Activating JAK2/STAT3/SOCS-1 Signaling Pathway
Zhang, Y., Zhou, B., Zhang, F., Wu, J., Hu, Y., Liu, Y., & Zhai, Q. (2012) · Diabetes · doi:10.2337/db11-0499 · Cited by 92
The Role of Neurovascular System in Neurodegenerative Diseases
Ahmad, A., Patel, V., Xiao, J., & Khan, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02023-z · Cited by 97
Wilkinson, K., Boyd, J. D., Glicksman, M. A., Moore, K. J., & Khoury, J. B. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.232116 · Cited by 90
Do, H., Pyo, S., & Sohn, E. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.03.013 · Cited by 88
Tichauer, J. E., & Rommy von Bernhardi, M. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23082 · Cited by 91
Puchałowicz, K., & Rać, M. E. (2020) · Cells · doi:10.3390/cells9081877 · Cited by 88
Driscoll, W. S., Vaisar, T., Tang, J., Wilson, C. L., & Raines, E. W. (2013) · Circulation Research · doi:10.1161/circresaha.112.300683 · Cited by 87
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
Lepiarz-Raba, I., Gbadamosi, I., Florea, R., Paolicelli, R. C., & Jawaid, A. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00382-w · Cited by 90
Zhang, K., Li, T. X., Liu, L., Feng, Y., Dong, Y.-B., Li, B., Shang, D., Fang, W., Cao, Y., & Chen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072744 · Cited by 89
Blood‐brain barrier damage in vascular dementia
Ueno, M., Chiba, Y., Matsumoto, K., Murakami, R., Fujihara, R., Kawauchi, M., Miyanaka, H., & Nakagawa, T. (2015) · Neuropathology · doi:10.1111/neup.12262 · Cited by 90
Neurotoxicity by microglia: Mechanisms and potential therapeutic strategy
Takeuchi, H. (2010) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2009.00001.x · Cited by 88
Fanlo-Ucar, H., Picón-Pagès, P., Herrera-Fernández, V., ILL‐Raga, G., & Muñoz, F. J. (2024) · Antioxidants · doi:10.3390/antiox13101208 · Cited by 94
CD36 in Alzheimer’s Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting
Dobri, A.-M., Dudău, M., Enciu, A., & Hinescu, M. E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.003 · Cited by 83
Genetic deletion of CD36 enhances injury after acute neonatal stroke
Woo, M., Wang, X., Faustino, J. V., Derugin, N., Wendland, M. F., Zhou, P., Iadecola, C., & Vexler, Z. S. (2012) · Annals of Neurology · doi:10.1002/ana.23727 · Cited by 82
The Evolving Biology of Microglia in Alzheimer's Disease
Malm, T. M., Jay, T. R., & Landreth, G. E. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0316-8 · Cited by 85
Activation of Human Platelets by Misfolded Proteins
Herczenik, E., Bouma, B., Korporaal, S. J. A., Strangi, R. D., Zeng, Q., Gros, P., Eck, M. V., van Berkel, T. J. C., Gebbink, M. F. B. G., & Akkerman, J. N. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.143479 · Cited by 86
Migration of blood cells to β-amyloid plaques in Alzheimer's disease
Hohsfield, L. A., & Humpel, C. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.03.002 · Cited by 79
Microglia as a critical player in both developmental and late-life CNS pathologies
Derecki, N. C., Katzmarski, N., Kipnis, J., & Meyer-Luehmann, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1321-z · Cited by 78
Sárvári, M., Hrabovszky, E., Kalló, I., Solymosi, N., Likó, I., Berchtold, N. C., Cotman, C. W., & Liposits, Z. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-264 · Cited by 81
Benito, C., Tolón, R. M., Castillo, A. I., Ruiz‐Valdepeñas, L., Martínez-Orgado, J. A., Fernández, J., Vázquez, C., Cravatt, B. F., & Romero, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01889.x · Cited by 81
Pellicanò, M., Bulati, M., Buffa, S., Barbagallo, M., Di Prima, A., Misiano, G., Picone, P., Di Carlo, M., Nuzzo, D., Candore, G., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091714 · Cited by 86
Han, R., Lan, X., Han, Z., Ren, H., Aafreen, S., Wang, W., Hou, Z., Zhu, T., Qian, A., Han, X., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122277 · Cited by 80
Untangling the role of amyloid in atherosclerosis
Howlett, G. J., & Moore, K. J. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000245260.63505.4f · Cited by 79
Bulgarelli, I., Tamiazzo, L., Bresciani, E., Rapetti, D., Caporali, S., Lattuada, D., Locatelli, V., & Torsello, A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22088 · Cited by 78
Microglial cells in neurodegenerative disorders.
Wojtera, M., Sikorska, B., Sobów, T., & Liberski, P. P. (2005) · PubMed · Cited by 78
Welcome, M. O. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08547-5 · Cited by 77
Cholesterol-related genes in Alzheimer's disease
Wollmer, M. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.009 · Cited by 78
Misfolded Truncated Protein τ Induces Innate Immune Response via MAPK Pathway
Kovac, A., Zilka, N., Kazmerova, Z., Cente, M., Zilkova, M., & Novak, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100216 · Cited by 75
Reitz, C. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110599 · Cited by 76
Fatty acid transporting proteins: Roles in brain development, aging, and stroke
Zhang, W., Chen, R., Yang, T., Xu, N., Chen, J., Gao, Y., & Stetler, R. A. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.04.004 · Cited by 79
Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer’s Disease
Chiarini, A., Armato, U., Hu, P., & Prà, I. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239036 · Cited by 77
Innate Immunity in Alzheimer’s Disease: A Complex Affair
Guillot‐Sestier, M., & Town, T. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050008 · Cited by 72
Microglia Ontology and Signaling
ElAli, A., & Rivest, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00072 · Cited by 75
Interaction of neurons and astrocytes underlies the mechanism of Aβ-induced neurotoxicity
Angelova, P. R., & Abramov, A. Y. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140153 · Cited by 71
Tribouillard‐Tanvier, D., Striebel, J. F., Peterson, K. E., & Chesebro, B. W. (2009) · Journal of Virology · doi:10.1128/jvi.01413-09 · Cited by 73
Adorni, M. P., Ruscica, M., Ferri, N., Bernini, F., & Zimetti, F. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00120 · Cited by 67
The Participation of Microglia in Neurogenesis: A Review
Pérez-Rodríguez, D. R., Blanco‐Luquin, I., & Mendióroz, M. (2021) · Brain Sciences · doi:10.3390/brainsci11050658 · Cited by 74
Ricciarelli, R., d'Abramo, C., Zingg, J.-M., Giliberto, L., Markesbery, W., Azzi, A., Marinari, U. M., Pronzato, M. A., & Tabaton, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.007 · Cited by 66
Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases
Ramos-Hryb, A. B., Pazini, F. L., Kaster, M. P., & Rodrigues, A. L. S. (2017) · CNS Drugs · doi:10.1007/s40263-017-0474-4 · Cited by 66
Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
Brown, M. R., Radford, S. E., & Hewitt, E. W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.609073 · Cited by 67
Foster, F., Kandanearatchi, A., Beasley, C. L., Williams, B. P., Khan, N., Fagerhol, M. K., & Everall, I. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05219.x · Cited by 62
Xu, Y., Au, N. P. B., & Ma, C. H. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896852 · Cited by 68
Microglial Activation in Metal Neurotoxicity: Impact in Neurodegenerative Diseases
Martínez-Hernández, M. I., Acosta‐Saavedra, L. C., Hernández‐Kelly, L. C., Loaeza‐Loaeza, J., & Ortega, A. (2023) · BioMed Research International · doi:10.1155/2023/7389508 · Cited by 63
Zhu, L., Yang, J., Xue, X., Dong, Y., Liu, Y., Miao, F.-R., Wang, Y., Xue, H., & Wu, C. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.07.002 · Cited by 59
Presenilin 2 Is the Predominant γ-Secretase in Microglia and Modulates Cytokine Release
Jayadev, S., Case, A., Eastman, A. J., Nguyen, H., Pollak, J., Wiley, J. C., Möller, T., Morrison, R. S., & Garden, G. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015743 · Cited by 60
Innate Immune Response Gene Expression Profiles of N9 Microglia Are Pathogen-Type Specific
McKimmie, C. S., Roy, D., Forster, T., & Fazakerley, J. K. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.012 · Cited by 51
Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer’s Disease
Tedeschi, P., Nigro, M., Travagli, A., Catani, M., Cavazzini, A., Merighi, S., & Gessi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136950 · Cited by 61
Griffiths, M. R., Gasque, P., & Neal, J. W. (2010) · International Journal of Inflammation · doi:10.4061/2010/151097 · Cited by 61
Qin, M., Wang, L., Li, F., Yang, M., Song, L., Tian, F., Yukht, A., Shah, P. K., Rothenberg, M. E., & Sharifi, B. G. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.05.011 · Cited by 58
Pharmacological exploration of traditional plants for the treatment of neurodegenerative disorders
Wahid, M., Ali, A., Saqib, F., Aleem, A., Bibi, S., Afzal, K., Ali, A., Baig, A., Khan, S. A., & Asad, M. H. H. B. (2020) · Phytotherapy Research · doi:10.1002/ptr.6742 · Cited by 61
CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia
Kim, E., Febbraio, M., Bao, Y., Tolhurst, A. T., Epstein, J. M., & Cho, S. (2012) · Annals of Neurology · doi:10.1002/ana.23569 · Cited by 58
Kim, E., Tolhurst, A. T., Szeto, H. H., & Cho, S. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12326 · Cited by 57
Macrophage Scavenger Receptor A Mediates Adhesion to Apolipoproteins A-I and E
Neyen, C. D., Plüddemann, A., Roversi, P., Thomas, B., Cai, L., van der Westhuyzen, D. R., Sim, R. B., & Gordon, S. (2009) · Biochemistry · doi:10.1021/bi9013769 · Cited by 56
Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas
Choi, S. H., Tamura, K., Khajuria, R. K., Bhere, D., Nesterenko, I., Lawler, J., & Shah, K. (2014) · Molecular Therapy · doi:10.1038/mt.2014.214 · Cited by 56
Park, L., Zhou, P., Koizumi, K., Jamal, S. E., Previti, M. L., Nostrand, W. E. V., Carlson, G. A., & Iadecola, C. (2012) · Stroke · doi:10.1161/strokeaha.112.670976 · Cited by 55
Interactions of HIV and Drugs of Abuse
Hauser, K. F., & Knapp, P. E. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00009-9 · Cited by 58
Lipid Players of Cellular Senescence
Millner, A., & Atilla‐Gokcumen, G. E. (2020) · Metabolites · doi:10.3390/metabo10090339 · Cited by 60
Neuroprotective Treatments for Ischemic Stroke: Opportunities for Nanotechnology
Kong, J., Chu, R., & Wang, Y. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202209405 · Cited by 54
Sun, Y., Wei, K., Liao, X., Wang, J., Gao, L., & Pang, B. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5580 · Cited by 63
Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
Asik, R. M., Suganthy, N., Aarifa, M. A., Kumar, A., Szigeti, K., Máthé, D., Gulyás, B. Z., Archunan, G., & Padmanabhan, P. (2021) · Biomedicines · doi:10.3390/biomedicines9091126 · Cited by 54
Wang, C., Wang, Z., Xie, J., Cai, J., Wang, T., Xu, Y., Wang, X., & Li, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5845 · Cited by 53
Genetic Ablation of CD36 Does not Alter Mouse Brain Polyunsaturated Fatty Acid Concentrations
Song, B. J., Elbert, A., Rahman, T., Orr, S. K., Chen, C. T., Febbraio, M., & Bazinet, R. P. (2010) · Lipids · doi:10.1007/s11745-010-3398-z · Cited by 51
Role of Microglia in Modulating Adult Neurogenesis in Health and Neurodegeneration
Al‐Onaizi, M., Al-Khalifah, A., Qasem, D., & ElAli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186875 · Cited by 60
Murgas, P., Godoy, B., & Rommy von Bernhardi, M. (2012) · Neurotoxicity Research · doi:10.1007/s12640-011-9306-3 · Cited by 50
Bignante, E. A., Heredia, F., Morfini, G. A., & Lorenzo, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.021 · Cited by 50
Doens, D., Valiente, P. A., Mfuh, A. M., Vo, A. X. T., Tristan, A., Carreño, L., Quijada, M. R., Nguyen, V. T., Perry, G. L., Larionov, O. V., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00386 · Cited by 49
Yuan, C., Guo, X., Zhou, Q., Du, F., Jiang, W., Zhou, X., Liu, P., Chi, T., Ji, X., Gao, J., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.028 · Cited by 49
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Reich, N., & Hölscher, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614828 · Cited by 48
“This receptor has been reported to act as an inflammatory conductor for Aß, leading to the production of ROS and proinflammatory cytokines upon the interaction of fibrillar Aß with microglial or macrophage CD36 (Coraci et al., 2002; Bamberger et al., 2003; El Khoury et al., 2003; Demers et al., 2004).”
BackgroundInfluentialMatsumoto, K., Chiba, Y., Fujihara, R., Kubo, H., Sakamoto, H., & Ueno, M. (2015) · Histochemistry and Cell Biology · doi:10.1007/s00418-015-1366-7 · Cited by 46
Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
Zhao, Y., Liu, B., Wang, J., Xu, L., Yu, S., Fu, J., Yan, X., & Su, J. (2022) · Biomedicines · doi:10.3390/biomedicines10081800 · Cited by 48
Venosa, A., Smith, L. C., Murray, A., Banota, T., Gow, A. J., Laskin, J. D., & Laskin, D. L. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz187 · Cited by 46
CD36 – A novel molecular target in the neurovascular unit
Ioghen, O., Chițoiu, L., Gherghiceanu, M., Ceafalan, L. C., & Hinescu, M. E. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15147 · Cited by 47
Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
Wells, C., Brennan, S. E., Keon, M., & Saksena, N. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00271 · Cited by 46
Kunjathoor, V. V., Tseng, A. A., Medeiros, L. A., Khan, T., & Moore, K. J. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-23 · Cited by 44
Cerebral sterile inflammation in neurodegenerative diseases
Otani, K., & Shichita, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00137-4 · Cited by 39
Role of CD36 in central nervous system diseases
Feng, M., Zhou, Q., Xie, H., Liu, C., Zheng, M., Zhang, S., Zhou, S., & Zhao, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.380821 · Cited by 43
Cheng, S., LeBlanc, K. J., & Li, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108845 · Cited by 42
Balkaya, M., Kim, I., Shakil, F., & Cho, S. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20924099 · Cited by 41
Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex
Leung, E., Guo, L., Bu, J., Maloof, M. E., Khoury, J. B. E., & Geula, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.025 · Cited by 40
Cellular transcriptional alterations of peripheral blood in Alzheimer’s disease
Song, L., Yang, Y., Guo, Q., & Zhao, X. (2022) · BMC Medicine · doi:10.1186/s12916-022-02472-4 · Cited by 40
SELENOK-dependent CD36 palmitoylation regulates microglial functions and Aβ phagocytosis
Ouyang, P., Cai, Z., Peng, J., Lin, S., Chen, X., Chen, C., Feng, Z., Wang, L., Song, G.-L., & Zhang, Z. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103064 · Cited by 40
Metadata
- Authors
- Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., & El Khoury, J. B.
- Affiliations
- Columbia University Irving Medical Center (US)
- Albert Einstein College of Medicine (US)
- Duke University (US)
- Harvard University (US)
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 160
- Issue
- 1
- Pages
- 101-112
- ISSN
- 0002-9440 (ISSN-L)
- PMC
- PMC1867121
- OpenAlex
- W2096519700
- Cited by
- 398
- References
- 56
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 13 · 2023: 10 · 2022: 16 · 2021: 18 · 2020: 29 · 2019: 17 · 2018: 10 · 2017: 16 · 2016: 16 · 2015: 18 · 2014: 29 · 2013: 18 · 2012: 33
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal Of Pathology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke
- National Heart, Lung, and Blood Institute (PO1-AG02219, P50-AG05138)
- Alzheimer's Association (R37-AI 20516)
- National Institute of Allergy and Infectious Diseases (HL43310)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- CD36, scavenger receptor class B, microglia, Alzheimer's disease, amyloid-beta fibrils, reactive oxygen species, hydrogen peroxide production, amyloid plaques, vascular endothelial cells, monoclonal antibody inhibition
- MeSH terms
- Alzheimer Disease, Animals, Antibodies, Brain, Cell Adhesion, Cell Line, Cell Line, Transformed, Fetus, Humans, Macrophages, Membrane Proteins, Peptide Fragments, Peroxides, Phagocytes, Receptors, Immunologic, Amyloid beta-Peptides, Reactive Oxygen Species, Microglia, Receptors, Lipoprotein, CD36 Antigens, Receptors, Scavenger, Scavenger Receptors, Class A, Scavenger Receptors, Class B, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review